Uli Broedl

Uli Broedl

Company: Boehringer Ingelheim

Job title: Head of Global Clinical Development & Operations


Targeting EMPEROR PRESERVE as an Entry Point in HFpEF Drug Development Success 10:45 am

Examine the results and findings of EMPEROR-Preserved Evaluate the learnings obtained from the trial Understand the impact of EMPEROR-Preserved on future developments in HFpEFRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.